innovationOchsner and Evidation Health Partner to Measure Digital Health Outcomes in Clinical Studies

Sigue a La Prensa en Facebook

NEW ORLEANS & MENLO PARK, Calif.–(BUSINESS WIRE)–Today innovationOchsner
(iO), an innovation lab and accelerator created by Ochsner
Health System
, announced a partnership with Evidation
Health
, a company launched by GE
Ventures
and Stanford
Health Care
.

This strategic partnership leverages the strengths of each organization
to conduct robust clinical studies to determine the real-world impact of
digital solutions on the health of patients and the cost of care. The
affiliation matches Ochsner Health System’s medical expertise and
diverse patient population, iO’s digital health capabilities, and
Evidation Health’s technology platform, data analytics engine and health
outcomes research capabilities to enable more efficient testing of
digital health solution impact.

With the digital landscape and greater healthcare industry changing
rapidly, embracing new technology and data sources is paramount in
developing solutions that can better meet the needs of consumers. iO is
pioneering digital health solutions, enabling Ochsner Health System to
adopt new technologies and integrate them into its patient care model.

Evidation Health’s technology platform and analytics capabilities enable
integration of medical, behavioral and contextual data to quantify
clinical and economic benefit. The company has the ability to link
patient behavioral data from over 100 apps and devices with clinical
data to understand and predict the impact of behaviors on health
outcomes.

“Our focus in digital health is to demonstrate real-world health
outcomes for patients, payers and provider systems, especially in
conditions where patient behavior can profoundly impact those outcomes.
Our partnership with Ochsner Health System and iO enables connections to
a large population of patients and researchers in all types of clinical
specialties to demonstrate how these innovative technologies can impact
healthcare outcomes and value,” said Deborah Kilpatrick, Ph.D., CEO of
Evidation Health.

“The partnership with Evidation Health continues our commitment to lead
and innovate in patient care. We are very excited about the opportunity
to study potentially impactful healthcare solutions to inform our own
clinical interventions as well as those of other health systems who are
looking for innovative solutions to care delivery,” said Richard
Milani, MD
, Ochsner Health System’s Chief Clinical Transformation
Officer and iO’s Chief Innovation Officer. “We see technology as a ripe
opportunity to engage patients in their care and empower them to take a
more active role in managing and monitoring their health. Having the
data to support this will allow us to further the development of our
innovative digital health programs.”

About Evidation Health

Evidation Health began as a collaboration between GE Ventures and
Stanford Health Care to realize a shared vision for a digital
health-enabled future. The company partners across the healthcare
ecosystem to generate real-world clinical and economic evidence enabled
by digital health solutions. Evidation Health helps partners quantify
and optimize health outcomes through advanced analytics of
medical, behavioral and contextual data at the patient-consumer level.
Evidation Health is based in Menlo Park, CA. For more information, go to www.evidation.com.

About Ochsner Health System

Ochsner Health System is Louisiana’s largest non-profit, academic
healthcare system. Driven by a mission to Serve, Heal, Lead, Educate and
Innovate, coordinated clinical and hospital patient care is provided
across the region by Ochsner’s 25 owned, managed and affiliated
hospitals and more than 50 health centers. Ochsner is the only Louisiana
hospital recognized by U.S. News & World Report as a “Best Hospital”
across six specialty categories caring for patients from all 50 states
and more than 90 countries worldwide each year. Ochsner employs 17,000
employees, over 1,000 physicians in over 90 medical specialties and
subspecialties and conducts more than 900 clinical research studies.
Ochsner Health System is proud to be a tobacco-free environment. For
more information, please visit ochsner.org and follow us on Twitter and
Facebook.

About innovationOchsner

innovationOchsner (iO) is an innovation lab and accelerator launched by
Ochsner Health System to develop new innovations designed to solve
healthcare’s most pressing problems by focusing on the needs of patients
and using the latest technology and data. iO is developing entirely new
ways for healthcare providers to dramatically improve the quality of
care by managing patient conditions more effectively and efficiently and
for patients to be empowered to take an active role in monitoring,
maintaining and enhancing their own health. For more information, please
visit innovationochsner.com.

Contacts

Ochsner
Kacey Hill, 504-858-7092
kacey.hill@ochsner.org
or
Evidation
Health
Shannon Bergstedt, 415-523-0412
shannon@evidation.com